Big Move For RNLX
RNLX (RNLX:NASDAQ) rocketted at $14.08, representing a gain of 31.7%. On Tue 24 Nov 20, RNLX:NASDAQ touched a New 2-Week Intraday High of $12.18. The stock got featured on our News Catalysts scanner on Wed 25 Nov 20 at 08:42 AM in the 'BIOTECH' category. From Tue 10 Nov 20, the stock recorded 50.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About RNLX (RNLX:NASDAQ)
Renalytix AI PLC is a developer of artificial intelligence-enabled clinical decision support solutions for kidney disease and costly chronic medical conditions globally. The company's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Top 10 Gainers:
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 104%
- Newborn Acquisition Corp. (NBAC:NASDAQ), 86.2%
- Mmtec, Inc. (MTC:NASDAQ), 67.5%
- ELYS (ELYS:NASDAQ), 59.57%
- Future FinTech Group Inc. (FTFT:NASDAQ), 40.19%
- Slack Technologies, Inc. (WORK:NYSE), 37.59%
- FSR (FSR:NYSE), 35.32%
- RNLX (RNLX:NASDAQ), 31.71%
- Appian Corporation (APPN:NASDAQ), 31.69%
- ZK International Group Co., Ltd. (ZKIN:NASDAQ), 30.29%